Karyopharm is a Massachusetts-based clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of blood cancer.
Business Model:
Revenue: $249.8M
Employees: 201-500
Address: 85 Wells Avenue
City: Newton
State: MA
Zip: 02459
Country: US
Karyopharm is a Massachusetts-based clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of blood cancer.
Contact Phone:
+16176580600
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
11/6/2013
Ticker Symbol:
KPTI
IPO Price:
$16/share
Amount Raised:
$109M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|